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Abstract
Objective To develop and validate a prognostic model for early death
in patients with traumatic bleeding.
Design Multivariable logistic regression of a large international cohort
of trauma patients.
Setting 274 hospitals in 40 high, medium, and low income countries
Participants Prognostic model development: 20 127 trauma patients
with, or at risk of, significant bleeding, within 8 hours of injury in the
Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage
(CRASH-2) trial. External validation: 14 220 selected trauma patients
from the Trauma Audit and Research Network (TARN), which included
mainly patients from the UK.
Outcomes In-hospital death within 4 weeks of injury.
Results 3076 (15%) patients died in the CRASH-2 trial and 1765 (12%)
in the TARN dataset. Glasgow coma score, age, and systolic blood
pressure were the strongest predictors of mortality. Other predictors
included in the final model were geographical region (low, middle, or
high income country), heart rate, time since injury, and type of injury.
Discrimination and calibration were satisfactory, with C statistics above
0.80 in both CRASH-2 and TARN. A simple chart was constructed to
readily provide the probability of death at the point of care, and a web
based calculator is available for a more detailed risk assessment (http:
//crash2.lshtm.ac.uk).
Conclusions This prognostic model can be used to obtain valid
predictions of mortality in patients with traumatic bleeding, assisting in
triage and potentially shortening the time to diagnostic and lifesaving
procedures (such as imaging, surgery, and tranexamic acid). Age is an
important prognostic factor, and this is of particular relevance in high
income countries with an aging trauma population.
Introduction
Each year around 4 million people die worldwide from
unintentional injury and violence, and tens of millions are left
permanently disabled. Most of the victims are from low and
middle income countries.1Althoughmany of these deaths occur
at the scene of the injury, 44% are estimated to occur after
admission to hospital.2
Severe bleeding accounts for about one third of in-hospital
deaths due to trauma and is an important contributory factor for
other causes of death, particularly head injury and multi-organ
failure.3 Failure to start appropriate early management in
bleeding trauma patients is a leading cause of preventable death
from trauma.4 Triage criteria that allow the rapid identification
of patients at high risk have the potential to reduce mortality
from trauma. Recent evidence that the early administration of
tranexamic acid substantially reduces mortality in bleeding
trauma patients further underscores the clinical importance of
the timely identification of life threatening bleeding.5However,
any such early prediction would have to be based on variables
that can be readily measured soon after injury. Several clinical
variables related to the physiological response to reduced
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intravascular volume predict the risk of death in bleeding trauma
patients. These include blood pressure, capillary refill time,
level of consciousness (Glasgow coma score), heart rate, and
respiratory rate.6 Because all of these variables are of limited
predictive value when considered in isolation, prognostic models
that combine variables are needed for better predictive
accuracy.7-9 An accurate and user friendly prognostic model to
predict mortality in patients with traumatic bleeding could assist
doctors and paramedics in pre-hospital triage, whether in civilian
or battlefield settings; its use could shorten the time to diagnostic
and lifesaving procedures (such as surgery and tranexamic acid).
We have previously published a prognostic model for patients
with traumatic brain injury, which was accurate, user friendly,
and clinically useful for supporting physicians’ decision
making.10 11
Existing prognostic models for bleeding trauma patients are
limited.12 Most were developed using data collected many
decades ago and havemethodological limitations. Models based
on contemporary data are needed, as treatment practices have
changed and the age of trauma patients has increased in high
income countries. Furthermore, although most deaths due to
trauma occur in low and middle income countries, most
prognostic models are based on data from high income
countries.12 We aimed to develop a simple prognostic model
that could be used at the point of care to estimate risk of death
in patients with traumatic bleeding.
Methods
Model development
For the development of the prognostic model, we involved
potential users from three settings: pre-hospital, battlefield, and
emergency departments. We held meetings with paramedics,
military doctors, and consultants in emergency medicine to
identify variables and interactions that they considered important
and convenient for their settings and to obtain information on
how to present the prognostic model in a user friendly format.
We included patients from the Clinical Randomisation of an
Antifibrinolytic in Significant Haemorrhage (CRASH-2) trial.13
The trial included 20 127 trauma patients with, or at risk of,
significant bleeding, within eight hours of injury, and took place
in 274 hospitals in 40 countries. The primary outcome was all
cause mortality. Patients’ outcomes were recorded at discharge,
at death in hospital, or 28 days after injury, whichever occurred
first.
Predictors
We took variables to be analysed as potential predictors from
the patients’ entry forms completed before randomisation.
Variables included in the entry form for the CRASH-2 trial can
be divided into patients’ demographic characteristics (age and
sex), characteristics of the injury (type of injury and time from
injury to randomisation), and physiological variables (Glasgow
coma score, systolic blood pressure, heart rate, respiratory rate,
and central capillary refill time).
Age was recorded as a continuous variable measured in years.
Type of injury had three categories—penetrating, blunt, or blunt
and penetrating—but we analysed it as “penetrating” or “blunt
and penetrating.” Time from injury was recorded as a continuous
variable measured in hours. The five physiological variables
were recorded according to usual clinical practice. For each of
these variables, the value given on the entry form was the first
measurement taken at hospital admission.
Multivariable analysis
We did complete case analysis, as the amount of missing data
was very low in CRASH-2. We initially included all candidate
predictors in the multivariable logistic regression. We adjusted
analyses for treatment by including treatment allocation as a
covariate in the models. We also included a variable for
economic region (that is, low, middle, or high income country,
as defined by the World Bank).14 We used logistic regression
models with random intercepts by country.We initially analysed
continuous variables as linear terms. We assessed departure
from linearity graphically and by adding quadratic and cubic
terms into the model. We specifically explored interactions by
age and by type of injury. We dichotomised time since injury
into less than or more than three hours, as the effect of this
variable was reasonably well captured by treating it as binary.
We used a backward stepwise approach. Firstly, we included
all potential prognostic factors and interaction terms that users
considered plausible. These interactions included all potential
predictors with type of injury, time since injury, and age. We
then removed, one at a time, terms for which we found no strong
evidence of an association, judged according to the P values
(<0.05) from the Wald test. Each time, we calculated a log
likelihood ratio test to check that the term removed did not have
a big effect in the model. Eventually, we reached a model in
which all terms were statistically significant. We used the R
software environment (version 2.13.1; R Foundation for
Statistical Computing, Vienna, Austria).
Performance
We assessed the predictive ability of the prognostic model in
terms of calibration and discrimination. Calibration indicates
whether observed risks agree with predicted risks; we assessed
this graphically by plotting the observed outcomes versus the
predicted probabilities of the outcomes. Discrimination indicates
whether patients at low risk can be separated from those at high
risk; we assessed this by using a concordance (C) statistic.15We
assessed optimism in the performance by bootstrap re-sampling.
We drew 200 samples with replacement from the original data,
with the same size as the original derivation data. In each
bootstrap sample, we repeated the entire modelling process,
including variable selection. We averaged the C statistics of
those 200 models in the bootstrap samples. We then estimated
the average C statistic when each of the 200 models was applied
in the original sample. The difference between the two average
C statistics indicated the “optimism” of the C statistic in our
prognostic model.15
External validation
For the external validation, we used the data from the Trauma
Audit and Research Network (TARN).Membership is voluntary
and includes 60% of hospitals receiving trauma patients in
England and Wales and some hospitals in Europe. Data are
collected on patients who arrive at hospital alive and meet any
of the following criteria: death from injury at any point during
admission, stay in hospital of longer than three days, need for
intensive or high dependency care, need for inter-hospital
transfer for specialist care.
We excluded patients with isolated closed limb injuries and
those over 65 years old with isolated fractured neck of femur
or pubic ramus fracture. The physiological data available in
TARN are identical to those in CRASH-2, in that for every
patient the heart rate, systolic blood pressure, Glasgow coma
score, respiratory rate, and capillary refill time on arrival are
entered by the hospital data coordinators. For each patient, the
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volume of blood loss is estimated. This is done by allocating
an estimated percentage of total volume of blood lost to each
injury code in the abbreviated injury scale dictionary by blinded,
then consensus, agreement from two emergency physicians.
This estimation is based on previous work on blood loss in
specific injuries.16
We selected adult (age over 15 years at the time of injury)
patients presenting between 2000 and 2008 to hospitals
participating in TARN. The definition of significant
haemorrhage used in the CRASH-2 trial was not available, so
we selected only patients with an estimated blood loss of at least
20%, whom we considered would be clinically comparable to
the CRASH-2 patients.
For the validation in the TARN dataset, we did multiple
imputations to substitute the missing values of the predictors
included in the prognostic model by using the procedure of
imputation by chained equations in Stata Release 11.We applied
the coefficients of the model developed in CRASH-2 with the
estimated UK intercept to the five imputed datasets of TARN,
obtaining five predictions of mortality for each patient in TARN.
We then averaged over these five predictions to calculate
calibration and discrimination.15
Simple prognostic model
For ease of use at the point of care, we developed a simple
prognostic model. For this model, we included the strongest
predictors with the same quadratic and cubic terms as used in
the full model, adjusting for tranexamic acid.
We presented the prognostic model as a chart that cross tabulates
these predictors with each of them recoded in several categories.
We made the categories by considering clinical and statistical
criteria. In each cell of the chart, we estimated the risk for a
person with values of each predictor at the mid-point of the
predictor’s range for that cell. We then coloured the cells of the
chart in four groups according to ranges of the probability of
death: <6%, 6-20%, 21-50%, and >50%. We decided these
cut-offs by considering feedback from the potential users of the
simple prognostic model and by looking at previous
publications.17 18
Results
Tables 1⇓ and 2⇓ show the characteristics of the patients in the
CRASH-2 and TARN datasets. In the CRASH-2 trial, most
patients were men and the median age was 30 years. Patients
who died were on average older and had lower systolic blood
pressure, higher heart rate, and lower Glasgow coma score than
those who did not. Few data were missing for all the variables.
In comparison, the patients from TARN were older (median
age 39 years) and had a higher systolic blood pressure. In all,
3076 (15%) deaths occurred among the 20 127 CRASH-2
patients and 1765 (12%) in the 14 220 TARN patients.
Age showed a positive and increasing association with risk of
death; systolic blood pressure, heart rate, and respiratory rate
showed U shaped relations; and Glasgow coma score had a
negative association with risk of death (fig 1⇓). Table 3⇓ shows
that in the CRASH-2 trial, age was positively associated with
mortality for each of the described causes of death; the highest
relative increase was for vascular occlusive death.
We included quadratic or cubic transformations in the prediction
model to accommodate for the departures from linearity. In the
multivariable analysis, Glasgow coma score, systolic blood
pressure, and age were the three strongest predictors. Heart rate,
respiratory rate, and hours since injury were associated with
mortality and were also included in the final model. Users
considered all of these variables to be important. Patients in low
and middle income countries were more likely to die in
comparison with those in high income countries. Although
capillary refill time was weakly associated with mortality, we
did not include it in the prognostic model because in situations
with poor visibility, such as in the battlefield, it is difficult to
measure. In addition, capillary refill time was missing in more
than 80% of the TARN patients. We found some evidence of a
statistical interaction between Glasgow coma score and type of
injury. Low Glasgow coma score was associated with worse
prognosis for blunt injuries (see web appendix for details of the
multivariable analysis).
Validation
The model showed a good internal validity, with a C statistic
of 0.84 (fig 2⇓) and good calibration, except in patients at very
high risk for whom the model over-predicted risk (fig 3⇓).
Internal validation using bootstrapping showed a minimal
decrease in the C statistic from 0.836 to 0.835. This indicates
that very low over-optimism existed in the development of the
model.
For the external validation, we used the same variables as were
included in the derivation model except hours since injury, as
this variable had a very large number of patients with missing
data. Discrimination was good (C statistic 0.88), and calibration
was satisfactory (figures 2⇓ and 3⇓).
Model presentation
The prognostic model is available at http://crash2.lshtm.ac.uk/
, so the risk of death can be obtained for individual patients.
Entering the values of the predictors results in display of the
expected risk of death at 28 days. For example, a 70 year old
patient from a low income country, with a Glasgow coma score
of 14, systolic blood pressure of 100 mm Hg, heart rate of 110
beats per minute, and respiratory rate of 35 breaths per minute,
has a 32% probability of death at 28 days.
Users also highlighted the importance of a simple prognostic
model that could be used at the bedside. The simple prognostic
model includes the three strongest prognostic variables: Glasgow
coma score, systolic blood pressure, and age (see appendix).
We developed different prognostic models for patients in low,
middle, and high income countries and presented them as charts
(fig 4⇓). These simple charts also showed good internal and
external calibration (fig 5⇓).
Discussion
We have developed and validated a prognostic model for trauma
patients by using clinical parameters that are easy to measure.
The model is available as a web calculator and can be used at
the point of care in its simplified form. Separate models are
available for patients from low, middle, and high income
countries. This simple prognostic model could inform doctors
about the risk of death and guide them in the early assessment
and management of trauma patients.
Strengths and limitations
Our study has several strengths. Our models were based on a
prospective cohort of patients with traumatic bleeding, with
standardised collection of data on prognostic factors, very little
missing data, and low loss to follow-up. Unlike previous
prognosticmodels, we exploredmore complex relations between
continuous predictors and mortality and captured non-linear
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relations. All of these factors provide reassurance about the
internal validity of our models. The large sample size in relation
to the number of prognostic variables is also an important
strength. Whereas most previous models were derived from
single centre studies in high income countries, we developed
separate models for low, middle, and high income countries.
Unlike most previous models, we did an external validation in
a large cohort of trauma patients. This confirmed the
discriminatory ability of the model in patients from high income
countries and showed good calibration.
Another methodological strength was our use of imputation to
replace missing data, which is rarely done in model validation
studies. To the best of our knowledge, this is the only prognostic
model for this population that is available in a web based
calculator and a simplified chart that can be used at point of
care. Importantly, we obtained advice from the potential users
throughout its development.
The study also has some limitations. The data from which the
models were developed come from a clinical trial, and this could
limit external validity. For example, patients were recruited
within eight hours of injury, andwe cannot estimate the accuracy
of the models for patients evaluated beyond this time.
Nevertheless, the CRASH-2 trial was a pragmatic trial that did
not require any additional tests and therefore included a diversity
of “real life” patients. In addition, the relation between predictors
and outcome could be different in patients included in a clinical
trial and in routine practice. However, the model’s good
performance in a trauma registry population provides
reassurance that any potential bias (if present) was small.
Another limitation was that for the validation we used a cohort
of trauma patients that were not equally defined, and we
included them by using an estimation of the blood loss. In any
case, this weakness could have led to underestimation of the
accuracy of the model. Other potentially important variables
such as pre-existing medical conditions, previous drugs, and
laboratory measurements were not collected in the CRASH-2
trial and, therefore, not available for inclusion in the model.
However, these are variables that are usually unavailable in the
acute care trauma setting in which the model is intended to be
used. The prognostic model predicts overall death rather than
death due to bleeding, as death due bleeding was not available
in the TARN dataset. However, bleeding would be expected to
contribute to the other main causes of death in trauma patients.
In addition, some deaths classified as “non-bleeding” could in
fact have been due to bleeding. Finally, we observed some
miscalibration; in particular, we observed overestimation for
patients with predicted high risk in the internal validation. This
finding might be related to the imprecision due to the low
number of patients in the very high risk group. Only 100 patients
(84 events) had a predicted risk of death above 90% in the
CRASH-2 dataset. However, miscalibration at this high risk
end of the spectrum (that is, 80% v 90% probability of death)
is very unlikely to change clinical decision making.
Implications of study
Many trauma protocols use blood pressure as the main criterion
for determining who should receive urgent intervention.
However, according to our model, a 75 year old with blunt
trauma and a systolic blood pressure of 110 mm Hg, heart rate
of 80 beats per minute, respiratory rate of 15 breaths per minute,
and Glasgow coma score of 15 has a similar risk of death to a
45 year old patient with exactly the same parameters but a
systolic blood pressure of 60 mm Hg. These findings have
important practical implications. According to many trauma
protocols, only the younger patient would receive urgent
interventions such as tranexamic acid, and the older one would
be denied this lifesaving intervention. The effect of age is
particularly important, bearing in mind that in high income
countries the average age of trauma patients is increasing. Data
from TARN show that one quarter of the deaths due to trauma
in England and Wales are in patients older than 70 years. The
effect of age is likely to reflect the increased incidence of
coexisting diseases, particularly cardiovascular diseases. Older
patients are more likely to have coronary heart disease, and the
decrease in oxygen supply associated with traumatic bleeding
can increase the risk of myocardial ischaemia.19 Another
potential explanation for the increased risk of death from
vascular occlusive disease is related to the trigger of the
inflammation process after trauma. After trauma, a potent
inflammatory response involves increased serum concentrations
of interleukin-1, interleukin-2, tumour necrosis factor-α,
interleukin-6, interleukin-12, and interferon-γ.20 In patients with
traumatic bleeding, activation of plasmin occurs and plays a
key role in the fibrinolytic response in the early hours after
injury. Plasmin also has pro-inflammatory effects through the
activation of cytokines, monocytes, neutrophils, platelets, and
endothelial cells.21 Vascular risk may rise in short time periods
of inflammatory responses to exposures such as infections or
major surgery.22 Some of the observed prognostic role of age
in trauma patients may be due to the inflammatory response to
acute trauma, which might trigger acute vascular events,
particularly in older patients who have a more widespread
atherosclerotic condition. Furthermore, the prognostic role of
age could be explained partially by a “self fulfilling prophecy”
phenomenon, as age has been shown to be positively associated
with “do not resuscitate” orders.23
We acknowledge that estimating the risk of death in a trauma
patient with bleeding is challenging. It is an ongoing process
that uses not only physiological variables but other variables
such as laboratory measurements and response to treatments.
A prognostic model would never replace clinical judgment, but
it can support it.
We found that trauma patients in low and middle income
countries were at higher risk of death compared with those from
high income countries. We emphasise that the income
classification refers to the country and not to individual patients.
Some of the effect of classification of income might be the
consequence of the differences in healthcare settings. Other
studies have shown similar results, but to our knowledge this
is the first one to include a large number of low and middle
income countries.24 Although we did not have enough
information to explore the causes of these differences, the rapid
increase in the number of trauma patients combined with the
lack of resources in poorer countries is probably among the
most important reasons. Scaling up cost effective interventions
in these settings could save hundreds of thousands of lives every
year.
Future research
The relation between age and mortality needs further
exploration. A better understanding of the mechanism by which
age is associated with increasingmortality could lead to effective
interventions to improve the outcome in this vulnerable
population. As we were able to validate the model only in
patients from high income regions, future studies should also
explore its performance in low and middle income countries.
Finally, future research should evaluate whether the use of this
prognostic model in clinical practice has an effect on the
management and outcomes of trauma patients.25
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What is already known on this topic
Failure to start appropriate early management in patients with traumatic bleeding is a leading cause of preventable death from trauma
An accurate and user friendly prognostic model to predict mortality could assist the appropriate early management in bleeding trauma
patients
The methodological quality of published prognostic models is generally poor, sample sizes are small, and only a few models have
included patients from low-middle income countries, where most deaths from trauma occur
What this study adds
An accurate and user friendly prognostic model to predict mortality in trauma patients with bleeding has been developed and validated
The prognostic model is available as a web based calculator, and a simplified model is available as a chart to be used at the bedside
This prognostic model can assist in triage and can shorten the time to diagnostic and lifesaving procedures such as imaging, surgery,
or tranexamic acid
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Tables
Table 1| Characteristics of CRASH-2 patients
Median (IQR) dead (n=3076)Median (IQR) alive (n=17 051)
All patients (n=20 127)
Characteristics Median (IQR)Missing (%)
35 (25-48)30 (23-42)30 (24-43)<1Age (years)
84 (70-100)100 (84-110)91 (80-110)<1Systolic blood pressure (mm Hg)
111 (96-126)104 (90-120)105 (90-120)<1Heart rate (beats per minute)
24 (20-30)22 (20-26)22 (20-26)<1Respiratory rate (breaths per minute)
8 (4-14)15 (13-15)15 (11-15)<1Glasgow coma score (total)
4 (3-5)3 (2-4)3 (2-4)3Capillary refill time (seconds)
2 (1-4)2 (1-4)2 (1-4)0Time since injury (hours)
IQR=interquartile range.
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Table 2| Characteristics of TARN patients
Median (IQR) dead (n=1765)Median (IQR) alive (n=12 455)
All patients (n=14 220)
Characteristics Median (IQR)Missing (%)
43 (27-70)38 (25-55)39 (25-57)0Age (years)
111 (88-140)130 (112-145)129 (110-145)16Systolic blood pressure (mmHg)
103 (80-126)87 (75-102)88 (75-105)16Heart rate (beats per minute)
22 (17-30)18 (16-23)19 (16-24)29Respiratory rate (breaths per minute)
12 (3-15)15 (15-15)15 (15-15)21Glasgow coma score (total)
1 (1-1)1 (1-1)1 (1-1)84Capillary refill time (seconds)
1 (1-1)1 (1-2)1 (1-2)64Time since injury (hours)
IQR=interquartile range.
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Table 3| Cause of death according to age in CRASH-2 patients. Values are numbers (percentages)
Any cause of deathOther causesHead injuryMulti-organ failureVascular occlusionBleedingAge (years)
661 (11.8)62 (1.1)247 (4.4)84 (1.5)8 (0.1)260 (4.6)<25 (n=5615)
1464 (14.8)115 (1.2)585 (5.9)207 (2.1)35 (0.3)522 (5.3)25-44 (n=9874)
556 (17.4)52 (1.6)220 (6.9)88 (2.8)19 (0.6)177 (5.6)45-59 (n=3188)
395 (27.3)37 (2.6)172 (11.9)63 (4.3)19 (1.3)104 (7.2)≥60 (n=1449)
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Figures
Fig 1 Association between continuous predictors and death among CRASH-2 patients
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Fig 2 Internal and external discrimination displayed by receiver operating characteristics curves. AUC=area under curve;
PV+=positive predictive value; PV–=negative predictive value
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Fig 3 Internal and external calibration of prognostic model by levels of predicted risk
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Fig 4 Chart to predict death in trauma patients. GCS=Glasgow coma score
Fig 5 Internal and external calibration of simple chart
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